Connect with us

Business

Blackmores banks on pets to overcome COVID crunch, drops Chinese medicine play – Sydney Morning Herald

The vitamin maker tells investors it plans to focus on pet supplements and mental health products as it seeks to get back on its feet following a big pandemic hit….

Published

on

Vitamins maker Blackmores is vowing to look beyond the COVID-19 pandemic and seek growth in mental health and pet supplements as it offloads an acquisition made by former chief Christine Holgate in 2016.
The $1.3 billion wellness business acknowledged at its annual general meeting on Tuesday the coronavirus pandemic had been a “huge challenge” for the company, but pointed to its continued strength in Australian and Asian markets and how its new Braeside facility had cemented its role as a local…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending